Anocca AB
556946-2384ActiveEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Översikt
- 100–199
- Anställda
- 750–999t SEK
- Omsättning
- 2013
- Grundat
Nyckelbeslutsfattare
Jacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
+34 fler kontakter i Funnelfeedr
Beskrivning
Anocca AB is a fully integrated, clinical-stage biopharmaceutical company based in Sweden. The organization specializes in creating libraries of T-cell receptor-engineered T cell (TCR-T) therapies. Their core mission is to redefine the treatment landscape for solid tumors, as well as infectious and...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556946238401
Beslutsfattare
38 kontakter i FunnelfeedrJacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
Martin Welschof
Board Member
Fredrik Hansson
Board Member
Sophie Blomqvist
Board Member
Mark Farmery
CDO
Christiane Hanke-Harloff
Board Member
Hans Stråberg
Chairman of the Board
Ragnar Lindqvist
Board Member
Luke Pase
Chief Technology Officer
Ryan Hill
Chief Information Officer
Zach Chia
VP Strategy & Business Development
Jan Lundberg
Board Member
Viktor Arnkil
Chief Operating Officer
Zahid Bashir
Chief Medical Officer
Reagan Jarvis
Chief Executive Officer, Scientific founder
Hugh Salter
Chief Scientific Officer
Niklas Sjökvist
Head of Production
Rehab Alnabhan
Clinical Science Lead
Mikael Pedin
HR Manager
Sheila Forsman
Director of Clinical Development
Malin Löfdahl
Director of GMP Operations
Dennis Ahlstedt
IT Manager
Athina Totomi
Platform Project Manager
Övriga kontakter
Sergey Zelenin
Principal Scientist
Richard Samuelson
Lead Software Engineer
Shenqiu Wang
Senior Scientist
Hannes Uchtenhagen
Principal Scientist
+8 fler kontakter i Funnelfeedr
Liknande företag
20 liknande företag i FunnelfeedrCuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Alvotech Sweden AB
20–49 anställdaDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Lokon Pharma AB
10–19 anställdaDeveloping novel gene engineering vectors for cancer immunotherapy.
Asgard Therapeutics AB
10–19 anställdaPioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Utforska mer
Frågor om Anocca AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo